Ungashe, S. B., Wei, Z., Rubas, W., Lai, N. L., Ertl, L., Baumgart, T., Wang, H., Miao, Z., Hor, S.-Y., Premack, B., Moore, J., Sullivan, E., Pennell, A., Keshav, S., Sanders, M., Howard, M., Wright, J. J. K., Bekker, P., & Schall, T. J. (2008). MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B. 235.

Ungashe, S. B., et al. MEDI 167-Discovery of the Highly Potent, Selective and Orally Bioavailable CCR9 Antagonist CCX282-B. 2008.

Ungashe, SB, Z Wei, W Rubas, NL Lai, L Ertl, T Baumgart, H Wang, et al. 2008. “MEDI 167-Discovery of the Highly Potent, Selective and Orally Bioavailable CCR9 Antagonist CCX282-B.” In . Vol. 235.